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Background:  Prostate cancer is the second most commonly diagnosed cancer globally. Cancer 
prehabilitation is defined as a process on the continuum of care that occurs between the time of a 
cancer diagnosis and the beginning of acute treatment. This article will discuss the importance of 
prostate cancer prehabilitation interventions in optimising physical and psychological recovery, to 
enhance person-centred care.   
Data Sources:  Electronic databases including CINAHL, MEDLINE, PsychINFO, Scopus, professional 
websites, and grey literature were searched using Google scholar. 
Conclusion:  Prehabilitation in cancer care aims to enhance perioperative care and recovery. An 
emerging field of research suggests that the preoperative period may be physically and psychologically 
salient to introduce modifiable self-management behaviours to optimise overall recovery.   
Implications for practice:  Prostate Cancer Specialist Nurses provide the hub of person-centred care 
across the entire cancer care continuum embedded within the multidisciplinary team.  Individually 
tailored interventions such as exercise and pelvic floor muscle training programmes, nutritional 
advice, anxiety and depression reduction, and sexual well-being interventions should be considered 
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Prostate cancer is the second most commonly diagnosed cancer globally 1. The worldwide prostate 
cancer burden is expected to grow to almost 2.3 million new cases by 2040 2. Radical treatments for 
localised prostate cancer include surgery and radiotherapy  which are associated with a negative 
impact on patients’ quality of life 3 and psycho-social outcomes 4. Specifically, many prostate cancer 
survivors experience ongoing adverse side effects which include: reduced physical function, fatigue, 
urinary incontinence, erectile dysfunction which negatively impact quality of life and psychological 
well-being5. Cancer prehabilitation is defined as a process on the continuum of care that occurs 
between the time of a cancer diagnosis and the beginning of acute treatment6. Interventions to 
enhance radical therapy recovery are often introduced post-treatment in clinical practice. The main 
approaches tend to target erectile dysfunction and urinary incontinence through the provision of 
pharmacological and/or pelvic floor muscle exercises.  Arguably, inadequate to address the person-
centred holistic care needs7.     
Prehabilitation offers a clinical route to improving the man’s physical and psychological status and 
may buffer treatment-related deconditioning between the time of diagnosis to post-treatment 
recovery8, see Figure 1. Prehabilitation includes physical and psychological assessments that establish 
baseline functioning and identify impairments that can impact on cancer treatment-related morbidity, 
as well as providing targeted interventions to optimise overall well-being prior to treatment 9.  Patients 
who are active and well-functioning prior to radical therapy recuperate faster, experience better 
recovery and have fewer complications compared to their less fit counterparts8. Existing reviews of 
prehabilitation interventions describe the benefit to postoperative physical and psychological well-
being, post-operative length of stay and surgical complications10,11. Therefore, the aim of this article is 
to provide an overview of prehabilitation multimodal interventions which could be used in practice to 
better support men affected by prostate cancer and his partner.        
Pelvic Floor exercises 
Radical prostatectomy (RP) is a common treatment for localised prostate cancer. Urinary incontinence 
is a common consequence of RP, which can cause a profound negative impact on quality of life12.  
Evidence synthesis on pelvic floor muscle training (PFMT) in men treated by RP is problematic due to 
divergence in methodologies, definitions of continence and the scheduling of the intervention13,14.  
However, recent clinical guidelines recommends that all men who opt for RP should have a proper 
assessment prior to PFMT intervention15. It is recommended, where possible, that qualified 
physiotherapists should ideally provide a clinical assessment and PFMT prescription for men opting 
for RP within the prehabilitation phase16.        
Sexual well-being 
Sexual well-being is an important component of the internal fabric of human beings, as sexual well-
being is not only concerned with the physical well-being but also the emotional, mental and social 
aspects of sexual health17,18. Sexual function remains an important issue in many men affected by 
prostate cancer and the most common treatment-related problem is erectile dysfunction19. In some 
men with prostate cancer, erectile dysfunction has become a larger problem than urinary 
incontinence and reports indicate that the level of sexual dysfunction is distressing enough to impact 
the individual’s self-esteem and partner relationships20,21. 
The treatment for erectile dysfunction can be very challenging for many health professionals, as no 
single treatment mode has proved more successful over another. Despite this, oral pharmacologically 
inhibiting phosphodiesterase type 5 (PDE5) inhibitors are traditionally the first choice of treatment 
22,23. PDE5 inhibitors are generally well-tolerated in most men however, they are contraindicated in 
men with diabetes, hypertension and coronary artery and in men with non-nerve sparing surgery24,25. 
PDE5 inhibitors do not contribute to the complete restoration of erectile function on its own, with 
current research indicating PDE5 inhibitors should be used in conjunction with other treatment 
therapies such as vacuum erection devices 26,27. 
Vacuum erection devices are considered an effective form of therapy for erectile dysfunction in men 
with prostate cancer and work best when initiated early within the rehabilitation program27,28,  as part 
of a uniformed therapeutic regime. Although vacuum erection devices are non-invasive and highly 
successful, men report that they are awkward to use, time-consuming and have a high risk of penile 
fibrosis in long term use19. Medicated urethral suppository for erections (MUSE) is another form of 
treatment for erectile dysfunction in men with prostate cancer. However, due to the invasive nature 
and high levels of pain and discomfort reported using MUSE, it is associated with non-compliance29 
and discontinuation of treatment30. 
Sexual counselling has been considered an effective treatment modality for erectile dysfunction, in 
combination with other treatments for individuals and couples25,31. Sexual counselling aims to address 
the patient and their partner’s anxiety and stress related to sexual well-being and support couple 
centred goals. Sexual counselling has associated with lower treatment discontinuation rates compared 
to those who did not receive sexual counselling29,31.  
Nutrition 
Nutrition has an important role in the prevention, management and survivorship of men with prostate 
cancer. The association between western diets and prostate cancer has been well documented, and 
includes certain nutrients such as fats, protein, carbohydrates and vitamins that have been attributed 
to prostate cancer disease progression at varying levels of evidence32-34. Current studies indicate a diet 
rich in fruit and vegetables, whilst replacing carbohydrates with whole grains and replacing red meat 
with fish is ideal for maintaining an appropriate body mass index in men with prostate cancer32,33. 
However, further high quality prospective randomised trials are needed as this area remains 
controversial.  
Diet modification has been proven to reduce the bowel side effects of prostate cancer treatment, 
maintain appropriate body mass index and improve quality of life in some men34. Diet and nutritional 
advice is an important aspect of prehabilitation and post rehabilitation care in men with prostate 
cancer however, the importance of nutrition is often overlooked by health professionals34.  
Exercise 
Exercise has been shown to impact many systems resulting in improved function, fitness, strength, 
cognition and quality of life in cancer patients35. Studies suggest that exercise during treatment for 
cancer will reduce potentially debilitating side effects and toxicities of treatments36,37. Optimally, for 
sedentary men diagnosed with prostate cancer38, a referral to an experienced exercise professional at 
diagnosis would ensure best health related outcomes from treatment and beyond. An early referral 
and introduction of an exercise program prior to treatment is recommended39,40. For most patients, a 
prescription of moderate to high intensity aerobic and resistance-based exercise would be appropriate 
however, there is currently no set prescription of exercise that would be considered evidence based 
for all men with prostate cancer38. A referral to an exercise specialist such as an Accredited Exercise 
Physiologist/ Clinical Exercise Physiologist or Physical Therapist/ Physiotherapist with cancer care 
experience is required, as they can provide an individualised program which includes behaviour 
change and support and also takes into consideration any existing co-morbidities to ensure the best 
patient outcomes in the short and long term38,41. 
Psychological well-being 
Diagnosis and treatment of prostate cancer often leads to a sequalae of negative events that can have 
a lasting impact on a man’s psychosocial well-being and overall quality of life42. It is not uncommon 
for these men to experience varying levels of psychological distress, which persists throughout the 
treatment trajectory. Traditional notions of male coping strategies indicate that men have the 
tendency to remain stoic in the face of adversity, as openly expressing their struggle can pose a threat 
to their perceived masculinity43,44. Consequently, this avoidance of emotion has been linked with 
reduced illness adjustment45,46 and almost one third of men have moderate to severe unmet 
psychosocial supportive care needs16. Newly diagnosed men face uncertainty about their future, with 
regards to disease outcome, and worry about the possibility of permanent physical limitations47. 
Therefore, they experience a noticeably higher incidence of anxiety and depression with reported 
rates of 27% and 17% respectively, which remains stable five years after treatment. Noteworthy, the 
increase in suicidal ideation that accompanies treatment, with a multicentre trial revealing up to 46% 
of men think of suicide following radical prostatectomy42,48. Men who adopt effective strategies to 
cope with cancer stressors, have the ability to self-manage challenges and have a solid foundation of 
social support are somewhat protected from the ill effects of their diagnosis46. However, the evidence 
has made it abundantly clear that ‘one size does not fit all’ and the unique needs of each man, along 
with the timing of interventions are vital planning considerations7,49. During the prehabilitation period 
men may be more motivated to address determinants of distress and implementing psychosocial 
interventions at this point can lead to an overall improvement in mood, well-being and immune 
function45,50.  
Patient Reported Outcome Measures (PRO’s) 
In the clinical setting, limited time and resources are acknowledged as challenges that impact on the 
ability of healthcare professionals to identify and address areas of unmet needs that arise during 
consultation 7,49. Therefore, efficiently detecting psychological distress in this population, at the point 
of diagnosis and beyond, is imperative for appropriate referral and timely intervention 44. Validated 
PRO’s have been supported for use in clinical practice as they provide insight into the patient 
experience, increase awareness of ongoing challenges, promote open-communication and lead to 
more-targeted self-management advice 7. The Distress Thermometer (DT) 51 has acceptable validity 
for use within the prostate cancer population. It is quick to administer and has demonstrated the 
ability to identify those men who require further psychological screening and assessment 49. Research 
has shown that the DT is highly accurate in detecting distress, anxiety and depression, when assessed 
against other outcome measures. It may even identify men susceptible to quality of life decrements 
who are not captured with other standard measures. Therefore, the DT is considered a valuable 
addition to psychosocial care plans for men with prostate cancer and prompt timely referrals to other 
healthcare professionals 44. 
Psychosocial Interventions 
There are a range of options available to support men with prostate cancer who have additional 
psychosocial needs. These include cognitive behavioural therapy (CBT) and cognitive behavioural 
stress management (CBSM), psychotherapy, psychoeducational support, peer support and self-
management interventions52-54. All of which can be implemented through a variety of mediums 
(online, telephone, face-to-face, individual or group delivery)52-54.  Parker et al55 provided a pre-
operative CBSM intervention that resulted in reduced mood disturbance up to and including the day 
of surgery however, there was no difference between the intervention and control groups post-
operatively. Penedo et al 56 also employed a CBSM program which was conducted within a group 
setting with a peer support component. Pendeo observed that the CBSM and peer support 
intervention enhanced quality of life outcomes. Peer discussions can provide emotional support, 
experiential information exchange and reduced feelings of social isolation. A Peer support network 
promotes cognitive and emotional processing, which in turn facilitates disease adaptation52. Schofield 
et al57  conducted a nurse-led psychoeducation group, which confirmed that group interventions could 
normalise experiences, bolster hope and assist with offsetting depressive symptoms and treatment 
related procedural concerns. However, this benefit did not translate to improvements in anxiety, 
unmet needs and prostate cancer specific quality of life.  
As there is a strong correlation between persistent symptom burden and psychological morbidity 58, 
evidence is emerging in favour of multimodal interventions that target physical, psychological, 
informational and self-management needs5. Paterson et al 59 trialled a multimodal supportive care 
intervention (ThriverCare) and observed a statistically significant reduction in the prevalence of unmet 
needs for those in the intervention group. However, there was no significant difference in depression 
and anxiety over time. As a way forward, this study highlighted the importance of developing 
individualised and flexible self-management plans that recognise the specific needs of each man as 
they change throughout treatment process. 
Person-centred care 
Health care professionals can practice person-centred care by treating men affected by prostate 
cancer with respect, providing honest, evidence-based information, making them feel valued as 
individuals and working in partnership by inviting them to take part in all decision about their care and 
daily life.  During the prehabilitation cancer trajectory and beyond, person-centred care is not a one-
time event, but rather every single patient-nurse consultation should be individualised and responsive 
to the unique person-centred needs across the entire cancer care continuum60. Supportive care is a 
person-centred approach to the provision of the necessary services for those living with or affected 
by cancer. It meets their informational, spiritual, emotional, social, or physical needs during diagnosis, 
treatment, or follow-up phases including issues of health promotion and prevention, survivorship, 
palliation and bereavement, see Figure 2 16. The prostate cancer model of consultation provides a 
conceptual framework which nurses can use in practice to ensure person-centred care across the 
entire cancer care continuum. Each member of the multidisciplinary team has defined roles in 
providing optimal care and treatment but as a collective team their contributions fit together and 
complement care delivery, like a jigsaw puzzle, tailored to the individual man and his partner. The 
Prostate Cancer Specialist Nurse acts as the “hub” along the cancer care continuum 7 embedded within 
the MDT.       
Conclusion 
Oncology nurses provide a key role in the development of prehabilitation person-centred care 
delivery. Prehabilitation is yet to be embedded as standard care practice however, emerging evidence 
conducted in prehabilitation interventions appears to have merit for men affected by prostate cancer.  
Additional research is needed to assess the longer-term physical and psychological outcomes of 
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